Circulating Levels of Endothelial Adhesion Molecules and Risk of Diabetes in an Ethnically Diverse Cohort of Women
- Yiqing Song1,
- JoAnn E. Manson123,
- Lesley Tinker4,
- Nader Rifai5,
- Nancy R. Cook13,
- Frank B. Hu23,
- Gokhan S. Hotamisligil6,
- Paul M. Ridker1,
- Beatriz L. Rodriguez789,
- Karen L. Margolis10,
- Albert Oberman11 and
- Simin Liu131213
- 1Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
- 2the Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
- 3Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts
- 4Fred Hutchinson Cancer Research Center, Seattle, Washington
- 5Children's Hospital, Harvard Medical School, Boston, Massachusetts
- 6Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts
- 7Department of Public Health Sciences and Epidemiology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii
- 8Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii
- 9Pacific Health Research Institute, Honolulu, Hawaii
- 10HealthPartners Research Foundation, Minneapolis, Minnesota
- 11Division of Preventive Medicine, Department of Medicine, School of Medicine, University of Alabama, Birmingham, Alabama
- 12Department of Epidemiology, School of Public Health, University of California, Los Angeles, California
- 13Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California
- Address correspondence and reprint requests to Dr. Simin Liu, Department of Epidemiology, UCLA School of Public Health, Box 951772, 650 Charles E. Young Dr. South, Los Angeles, CA 90095. E-mail: siminliu{at}ucla.edu
Abstract
Elevated circulating levels of soluble adhesion molecules as markers of endothelial dysfunction have been related to insulin resistance and its associated metabolic abnormalities. However, their associations with type 2 diabetes remain inconclusive. We conducted a prospective nested case-control study to examine the associations between plasma levels of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) and diabetes risk among 82,069 initially healthy women aged 50–79 years from the Women's Health Initiative Observational Study. During a median follow-up of 5.9 years, 1,584 incident diabetes case subjects were matched with 2,198 control subjects by age, ethnicity, clinical center, time of blood draw, and follow-up time. Baseline median levels of the biomarkers were each significantly higher among case subjects than among control subjects (E-selectin, 49 vs. 37 ng/ml; ICAM-1, 324 vs. 280 ng/ml; and VCAM-1, 765 vs. 696 ng/ml [all P values <0.001]). After adjustment for risk factors, the relative risks of diabetes among women in the highest quartile versus those in the lowest quartile were 3.46 for E-selectin (95% CI 2.56–4.68; P for trend <0.0001), 2.34 for ICAM-1 (1.75–3.13; P for trend <0.0001), and 1.48 for VCAM-1 (1.07–2.04; P for trend = 0.009). E-selectin and ICAM-1 remain significant in each ethnic group. In conclusion, higher levels of E-selectin and ICAM-1 were consistently associated with increased diabetes risk in a multiethnic cohort of U.S. postmenopausal women, implicating an etiological role of endothelial dysfunction in the pathogenesis of type 2 diabetes.
- CRP, C-reactive protein
- CVD, cardiovascular disease
- HOMA-IR, insulin resistance index estimated using the homeostasis model assessment
- ICAM-1, intercellular adhesion molecule-1
- VCAM-1, vascular cell adhesion molecule-1
Footnotes
-
Published ahead of print at http://diabetes.diabetesjournals.org on 27 March 2007. DOI: 10.2337/db07-0250.
Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/db07-0250.
-
- Accepted March 20, 2007.
- Received February 20, 2007.
- DIABETES














